Research Output per year
Personal profile
Personal Statement
My research interest is, broadly speaking, rational use of medicines, mainly focusing on pharmacoepidemiology – particularly drug utilisation – but also comprising related areas such as health policy. Topics include drugs used in cancer and cardiovascular disease; antimicrobial stewardship; drug adherence and treatment outcomes; and electronic record linkage. While mostly applying a range of statistical methods, I am also interest in mixed-methods approaches.
Education/Academic qualification
Master of Public Health, Lund University
Aug 2012 → Jun 2014
Doctor of Philosophy, UNIVERSITY OF STRATHCLYDE
Oct 2014 → Nov 2017
Master of Science, MALMO HOGSKOLA Malmoe University
Aug 2013 → Aug 2014
Bachelor of Arts, Europaische Fernhochschule Hamburg
Oct 2008 → Sep 2011
Keywords
- Pharmacy Practice
- Epidemiology
- Public Health
Fingerprint Dive into the research topics where Tanja Mueller is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 8 Similar Profiles
Scotland
Medicine & Life Sciences
Anticoagulants
Medicine & Life Sciences
Atrial Fibrillation
Medicine & Life Sciences
Drug Utilization
Medicine & Life Sciences
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Safety
Medicine & Life Sciences
Stroke
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2016 2019
Comparative safety and effectiveness of direct oral anticoagulants in patients with atrial fibrillation in clinical practice in Scotland
Mueller, T., Alvarez-Madrazo, S., Robertson, C., Wu, O. & Bennie, M., 20 Jan 2019, In : British Journal of Clinical Pharmacology. 85, 2, p. 422-431 10 p.Research output: Contribution to journal › Article
Open Access
File
Scotland
Anticoagulants
Atrial Fibrillation
Safety
Hemorrhage
Time to review authorisation and funding for new cancer medicines in Europe? Inferences from the case study with olaratumab
Pontes, C., Zara, C., Torrent, J., Obach, M., Nadal, C., Vella Bonanno, P., Ermisch, M., Simoens, S., Curi Hauegen, R., Gulbinovic, J., Timoney, A., Martin, A. P., Mueller, T., Nachtnebel, A., Campbell, S., Selke, G., Bochenek, T., Rothe, C. C., Mardare, I., Bennie, M. & 3 others, 7 Nov 2019, In : Applied Health Economics and Health Policy. 21 p.Research output: Contribution to journal › Article
Marketing
Neoplasms
Doxorubicin
Therapeutics
Risk Reduction Behavior
Thesis
Use of direct oral anticoagulants in Scotland
Author: Mueller, T., 1 Oct 2017Supervisor: Bennie, M. (Supervisor) & Johnston, B. (Supervisor)
Student thesis: Doctoral Thesis
Activities 2015 2019
Frontiers in Pharmacology (Journal)
Tanja Mueller (Peer reviewer)2019
Activity: Publication peer-review and editorial work types › Journal peer review
European Journal of Haematology (Journal)
Tanja Mueller (Peer reviewer)2019
Activity: Publication peer-review and editorial work types › Journal peer review